Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Eur J Trauma Emerg Surg ; 48(3): 1993-2001, 2022 Jun.
Article in English | MEDLINE | ID: mdl-33712893

ABSTRACT

BACKGROUND: The management of complicated ventral hernias (CVH), namely ventral hernias in actively or recently infected/contaminated operative fields, and open abdomens in which the native fascia cannot be primarily reapproximated, pose a surgical challenge. Fetal Bovine and Porcine Acellular Dermal Matrix (BADM and PADM) biologic meshes are being increasingly used in these scenarios. A comparison, however, of clinically relevant outcomes between the two is lacking. With this investigation, we aim to review and compare clinically relevant outcomes in patients that underwent abdominal wall herniorrhaphy with either BADM or PADM at a tertiary urban academic institution over a 5-year period. METHODS: Patients who had a BADM or PADM implanted during CVH over a 5-year period at a tertiary urban academic hospital were identified. Baseline clinical and hernia characteristics, as well as postoperative outcomes were compared after a retrospective chart review. Phone interviews were also conducted to assess for recurrence, followed by in-person visits as indicated. Cox Proportional Hazard regression was fitted to identify risk factors for recurrence. RESULTS: Of the 140 patients who underwent biologic mesh implantation for CVH, 109 were for ventral hernia repair and 31 for open abdomen bridging. Mean age was 52.7 ± 14.2 and males constituted 57.9% of our sample, while 25.1% had undergone > 5 prior abdominal operations. Thirty percent were active smokers, and another 30% required emergency surgery. Only immunosuppression was a risk factor for recurrence [HR 13.3 (1.04-169.2), p = 0.047] on Cox Proportional Hazard regression, while mesh selection had no effect. CONCLUSIONS: Both BADM and PADM meshes perform well in CVH, with satisfactory recurrence rates, only slightly higher compared to traditional synthetic mesh repairs.


Subject(s)
Abdominal Wall , Acellular Dermis , Biological Products , Hernia, Ventral , Abdominal Wall/surgery , Animals , Cattle , Hernia, Ventral/etiology , Hernia, Ventral/surgery , Herniorrhaphy/adverse effects , Humans , Male , Recurrence , Retrospective Studies , Surgical Mesh , Swine , Treatment Outcome
2.
World J Surg ; 43(3): 937-943, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30478680

ABSTRACT

BACKGROUND: Routine preoperative staging in pancreas cancer is controversial. We sought to evaluate the rates of diagnostic laparoscopy (DLAP) for pancreatic cancer. METHODS: We queried the National Surgical Quality Improvement Program for patients with pancreas cancer (2005-2013) and compared groups who underwent DLAP, exploratory laparotomy (XLAP), pancreas resection (RSXN) or therapeutic bypass (THBP). We compared demographics, comorbidities, postoperative complications, 30-day mortality (Chi-square P < 0.05) and trends over time (R2 0-1). RESULTS: We identified 17,138 patients (RSXN 81.8%, XLAP 16.5%, THBP 8.2%, and DLAP 12.9%), with some having multiple CPT codes. Only 10.3% (n = 1432) of RSXN patients underwent DLAP prior to resection. XLAP occurred in 49.5% of non-RSXN patients, of whom 67.1% had no other operation. The percentage of patients undergoing RSXN increased 20.3% over time (R2 0.81), while DLAP decreased 52.6% (R2 0.92). XLAP patients without other operations decreased from 4.2 to 2.4%, although not linearly (R2 0.31). Only 10.3% of XLAP had a diagnostic laparoscopy as well, leaving nearly 90% of these patients with an exploratory laparotomy without RSXN or THBP. DISCUSSION: Diagnostic laparoscopy for pancreas malignancy is becoming less common but could benefit a subset of patients who undergo open exploration without resection or therapeutic bypass.


Subject(s)
Laparoscopy/trends , Pancreatectomy/trends , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/surgery , Quality Improvement , Aged , Databases, Factual , Female , Humans , Laparoscopy/statistics & numerical data , Laparotomy/trends , Male , Middle Aged , Neoplasm Staging/methods , Neoplasm Staging/trends , Outcome Assessment, Health Care , Postoperative Complications/surgery
3.
J Vasc Surg ; 68(4): 1023-1029.e2, 2018 10.
Article in English | MEDLINE | ID: mdl-29602472

ABSTRACT

OBJECTIVE: Percutaneous endovascular aneurysm repair (EVAR) can be performed with general anesthesia (GA) or local anesthesia (LA). Our goal was to assess perioperative outcomes comparing anesthesia type in percutaneous EVAR. METHODS: The Vascular Quality Initiative database was queried for all exclusively percutaneous EVAR procedures. Univariable analysis was used to compare which patients were offered LA. Multivariable analysis was used to determine the independent effect of anesthesia type. RESULTS: There were 8141 percutaneous EVARs identified in the Vascular Quality Initiative database. Average age was 73 years, and 83% were male. GA and LA were used in 7387 (90.7%) and 754 (9.3%) cases, respectively. GA was used more often in patients who were younger (72.8 ± 8 vs 74.3 ± 9), white (89% vs 84.5%), and on Medicare (62% vs 61.5%); in patients with higher body mass index (28.3 ± 6 vs 27.3 ± 7), hypertension (81.5% vs 77.8%), diabetes (20.5% vs 17.4%), and previous lower extremity bypass (1.7% vs 0.5%); and in patients undergoing elective repair (86.4% vs 81.3%). Use of GA was associated with lower rates of preoperative congestive heart failure (11.6% vs 16.1%), preoperative anticoagulation (11.7% vs 14.2%), and less use of ultrasound guidance (81.5% vs 88.8%; P < .05). There was no difference in patients with chronic obstructive pulmonary disease, coronary artery disease, previous aneurysm repair, and concomitant iliac aneurysm repair. Multivariable analysis showed that GA compared with LA was associated with more pulmonary complications (odds ratio, 2.8; 95% confidence interval, 1.49-5.43; P = .002) and prolonged operative time (means ratio, 1.11; 95% confidence interval, 1.08-1.52; P < .001). There was no independent effect on overall complications, cardiac complications, or mortality. CONCLUSIONS: Although it was used in only 1 in 10 cases of percutaneous EVAR, LA was associated with fewer pulmonary complications after adjustment for patient factors. Surgeons should consider expanding the use of LA for percutaneous EVAR when feasible.


Subject(s)
Anesthesia, General , Anesthesia, Local , Aortic Aneurysm, Abdominal/surgery , Blood Vessel Prosthesis Implantation/methods , Endovascular Procedures/methods , Respiratory Tract Diseases/etiology , Age Factors , Aged , Aged, 80 and over , Anesthesia, General/adverse effects , Anesthesia, General/mortality , Anesthesia, Local/adverse effects , Anesthesia, Local/mortality , Aortic Aneurysm, Abdominal/mortality , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/mortality , Chi-Square Distribution , Comorbidity , Databases, Factual , Endovascular Procedures/adverse effects , Endovascular Procedures/mortality , Female , Health Status , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Propensity Score , Respiratory Tract Diseases/mortality , Retrospective Studies , Risk Factors , Treatment Outcome
4.
Front Surg ; 4: 14, 2017.
Article in English | MEDLINE | ID: mdl-28349051

ABSTRACT

This article provides a theoretical and practical rational for the implementation of an innovative and comprehensive social wellness program in a surgical residency program at a large safety net hospital on the East Coast of the United States. Using basic needs theory, we describe why it is particularly important for surgical residency programs to consider the residents sense of competence, autonomy, and belonging during residence. We describe how we have developed a comprehensive program to address our residents' (and residents' families) psychological needs for competence, autonomy, and belongingness.

5.
J Vasc Surg ; 65(4): 1039-1046, 2017 04.
Article in English | MEDLINE | ID: mdl-28041804

ABSTRACT

OBJECTIVE: Endovascular interventions of the common (CFA) and deep (DFA) femoral arteries are becoming more common. However, there is very little published data for guidance. Our objective was to analyze practice patterns and outcomes from these interventions. METHODS: The Vascular Quality Initiative (2010-2015) was queried for all endovascular interventions of the CFA and DFA. Cases that were emergent or for acute limb ischemia were excluded. Those with isolated CFA with or without DFA treatment were analyzed. RESULTS: There were 1014 patients that had either an isolated CFA intervention (946) with or without a DFA intervention (68). Average age of this isolated cohort was 67.4 ± 10.8 years, and 59% were male. Indications were claudication (67%), rest pain (16.3%), and tissue loss (16.7%). Periprocedural complications were access site hematoma (5.2%), arterial dissection (2.9%), distal embolization (0.7%), access site stenosis/occlusion (0.5%), and arterial perforation (0.6%). Thirty-day mortality was 1.6%. Survival was 92.9% at 1 year and 87.2% at 3 years. Amputation-free survival, freedom from loss of patency or death, and reintervention-free survival were 93.5%, 83%, and 87.5% at 1 year, respectively, by Kaplan-Meier analysis. Multivariable predictors of mortality were tissue loss, chronic obstructive pulmonary disease (COPD), end-stage renal disease, urgent case, and age, whereas aspirin use and non-Caucasian race were protective. Tissue loss, rest pain, COPD, end-stage renal disease, stent use, nonambulatory status, and female sex were predictive of major amputation whereas aspirin use, P2Y12 antagonist use, statin use, and initial technical success were protective. Tissue loss, case urgency and nonambulatory status predicted patency loss or death. Tissue loss, COPD, stent use, and history of prior bypass predicted reintervention. CONCLUSIONS: Endovascular interventions of the CFA/DFA have a low rate of periprocedural morbidity and mortality. One-year patency is lower than historically observed for CFA endarterectomy. Stent use is associated with reinterventions and amputation. Longer-term analysis is needed to better assess durability.


Subject(s)
Endarterectomy , Endovascular Procedures , Femoral Artery , Peripheral Arterial Disease/therapy , Quality Improvement , Quality Indicators, Health Care , Aged , Amputation, Surgical , Disease-Free Survival , Endarterectomy/adverse effects , Endarterectomy/mortality , Endarterectomy/standards , Endovascular Procedures/adverse effects , Endovascular Procedures/instrumentation , Endovascular Procedures/mortality , Endovascular Procedures/standards , Female , Femoral Artery/diagnostic imaging , Femoral Artery/physiopathology , Humans , Kaplan-Meier Estimate , Limb Salvage , Male , Middle Aged , North America , Peripheral Arterial Disease/diagnostic imaging , Peripheral Arterial Disease/mortality , Peripheral Arterial Disease/physiopathology , Quality Improvement/standards , Quality Indicators, Health Care/standards , Retreatment , Risk Factors , Stents , Time Factors , Treatment Outcome , Vascular Patency
6.
Am Surg ; 81(5): 527-31, 2015 May.
Article in English | MEDLINE | ID: mdl-25975341

ABSTRACT

Central venous catheterization (CVC) is often necessary during initial trauma resuscitations, but may cause complications including catheter-related blood stream infection (CRBSI), deep venous thrombosis (DVT), pulmonary emboli (PE), arterial injury, or pneumothoraces. Our primary objective compared subclavian versus femoral CVC complications during initial trauma resuscitations. A retrospective review (2010-2011) at an urban, Level-I Trauma Center reviewed CVCs during initial trauma resuscitations. Demographics, clinical characteristics, and complications including: CRBSIs, DVTs, arterial injuries, pneumothoraces, and PEs were analyzed. Fisher's exact test and Student's t test were used; P ≤ 0.05 was considered statistically significant. Overall, 504 CVCs were placed (subclavian, n = 259; femoral, n = 245). No difference in age (47 ± 22 vs 45 ± 23 years) or body mass index (28 ± 6 vs 29 ± 16 kg/m(2)) was detected (P > 0.05) in subclavian vs femoral CVC, but subclavian CVCs had more blunt injuries (81% vs 69%), greater systolic blood pressure (95 ± 55 vs 83 ± 43 mmHg), greater Glasgow Coma Scale (10 ± 5 vs 9 ± 5), and less introducers (49% vs 73%) than femoral CVCs (all P < 0.05). Catheter related arterial injuries, PEs, and CRBSIs were similar in subclavian and femoral groups (3% vs 2%, 0% vs 1%, and 3% vs 3%; all P > 0.05). Catheter-related DVTs occurred in 2 per cent of subclavian and 9 per cent of femoral CVCs (P < 0.001). There was a 3 per cent occurrence of pneumothorax in the subclavian CVC population. In conclusion, both subclavian and femoral CVCs caused significant complications. Subclavian catheter-related pneumothoraces occurred more commonly and femoral CRBSIs less commonly than expected compared with prior literature in nonemergent scenarios. This suggests that femoral CVC may be safer than subclavian CVC during initial trauma resuscitations.


Subject(s)
Catheterization, Central Venous/adverse effects , Catheterization, Central Venous/methods , Emergency Treatment , Femoral Vein , Resuscitation , Subclavian Vein , Wounds and Injuries/therapy , Female , Humans , Male , Middle Aged , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...